The 61-bed inpatient rehabilitation hospital is Encompass Health's first hospital fully constructed using prefabricated modules.

BIRMINGHAM, Ala., and HOUSTON, Nov. 11, 2024 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Houston at The Medical Center in Texas. The 61-bed inpatient rehabilitation hospital, located at 3010 Yellowstone Blvd., is Encompass Health's first hospital fully constructed using prefabricated modules. This innovative construction method, pursued in collaboration with Alabama-based company, BLOX, resulted in enhanced quality control, less waste and a condensed design and construction timeline―enabling Encompass Health Rehabilitation Hospital of Houston at The Medical Center to serve Houston patients sooner.

BIRMINGHAM, Ala. and WESLEY CHAPEL, Fla., Nov. 4, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in the master planned community of Wiregrass Ranch in Wesley Chapel, Florida.

The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care will be provided by highly specialized nurses, therapists and physicians.

Increases full-year guidance

BIRMINGHAM, Ala., Oct. 28, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2024.

Summary results

Growth

Q3 2024

Q3 2023

Dollars

Percent

(In Millions, Except Per Share Data)

Net operating revenue

$      1,351.0

$      1,206.9

$     144.1

11.9 %

Income from continuing operations attributable to Encompass Health per diluted share

1.07

0.85

0.22

25.9 %

Adjusted earnings per share

1.03

0.86

0.17

19.8 %

Cash flows provided by operating activities

267.8

215.2

52.6

24.4 %

Adjusted EBITDA

269.3

237.5

31.8

13.4 %

Adjusted free cash flow

189.7

149.3

40.4

27.1 %

(Actual Amounts)

Discharges

62,715

57,665

8.8 %

   Same-store discharge growth

6.8 %

Net patient revenue per discharge

$       20,987

$       20,472

2.5 %

BIRMINGHAM, Ala., Oct. 22, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $100 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes"). The associated redemption date will be November 21, 2024, and the redemption price will be 100.0% of par, plus accrued and unpaid interest pursuant to the terms of the 2025 Notes. The Company plans to use cash on hand to fund the redemption. As a result of this redemption, the Company expects to record an approximate $0.2 million loss on early extinguishment of debt in the fourth quarter of 2024.

BIRMINGHAM, Ala., Oct. 17, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Jan. 15, 2025, to holders of record on Jan. 2, 2025.

About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 165 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Becker's Hospital Review's 150 Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.

BIRMINGHAM, Ala., Oct. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept. 30, 2024, after the market closes on Monday, Oct. 28, 2024. The Company will host an investor conference call at 10 a.m. ET on Tuesday, Oct. 29, 2024, to discuss its results.

The conference call may be accessed by dialing 800-343-4849 and giving the conference ID EHCQ324. International callers should dial 203-518-9848 and give the same conference ID. Please call approximately 10 minutes before the start of the call to ensure you are connected.

The 39-bed inpatient rehabilitation hospital is Encompass Health's 165th hospital.

BIRMINGHAM, Ala. and FORT MILL, S.C., Sept. 24, 2024 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation of Fort Mill in South Carolina. The 39-bed inpatient rehabilitation hospital, located at 2260 Vista Road, is Encompass Health's 165th hospital nationwide and its ninth hospital in South Carolina.

BIRMINGHAM, Ala., July 24, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors approved an increase in the Company's quarterly dividend of approximately 13% and declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Oct. 15, 2024, to holders of record on Oct. 1, 2024.

Encompass Health also announced its board approved resetting the aggregate common stock repurchase authorization to $500 million. The Company repurchased approximately $17 million of its common stock during the second quarter and had approximately $181 million remaining under the prior authorization as of June 30, 2024.

BIRMINGHAM, Ala., July 15, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $150 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes"). The associated redemption date will be August 15, 2024, and the redemption price will be 100.0% of par, plus accrued and unpaid interest pursuant to the terms of the 2025 Notes. The Company plans to use cash on hand to fund the redemption. As a result of this redemption, the Company expects to record an approximate $0.4 million loss on early extinguishment of debt in the third quarter of 2024.

BIRMINGHAM, Ala., July 11, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2024, after the market closes Monday, Aug. 5, 2024. The Company will host an investor conference call at 10 a.m. ET on Tuesday, Aug. 6, 2024, to discuss its results.

The conference call may be accessed by dialing 800-579-2543 and entering the conference ID EHCQ224. International callers should dial 785-424-1699 and provide the same conference ID. Please call approximately 10 minutes before the start of the call to ensure you are connected.